Analyst Ratings (USA)
American analyst sentiment on November 11th remains mixed and increasingly cautious, with notable downgrades across artificial intelligence, semiconductors, software, financial services and energy highlighting concerns about elevated valuations, slowing earnings momentum and profitability. NVIDIA’s downgrade and substantial price-target reductions for CoreWeave suggest growing scrutiny of AI infrastructure investment and its long-term returns. However, upgrades for Apple and select industrial, healthcare and financial companies, alongside positive new coverage of semiconductor equipment and automation businesses, demonstrate continued confidence in structural growth opportunities.
Updates (315)
908 Devices (MASS) — Stifel Nicolaus maintains its Buy rating and raises its price target to $14.00 from $12.00.
Acrivon Therapeutics (ACRV) — Jefferies Financial Group maintains its Buy rating.
Adobe (ADBE) — Royal Bank Of Canada maintains its Outperform rating with a price target of $315.00.
Akamai Technologies (AKAM) — Evercore ISI downgrades from Outperform to In-line with a price target of $90.
Alamo Group (ALG) — DA Davidson maintains its Neutral rating and lowers its price target to $161.00 from $188.00.
Alliance Laundry (ALH) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $31.00 from $32.00.
Alliance Laundry (ALH) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $29.00 from $28.00.
Alliance Laundry (ALH) — Robert W. Baird maintains its Outperform rating and lowers its price target to $30.00 from $34.00.
Alpha Tau Medical (DRTS) — Piper Sandler upgrades from Neutral to Overweight and raises its price target to $22.00 from $8.00.
Alto Neuroscience (ANRO) — BTIG Research maintains its Buy rating with a price target of $37.00.
Ambiq Micro (AMBQ) — Needham & Company LLC maintains its Buy rating and lowers its price target to $65.00 from $85.00.
Ambiq Micro (AMBQ) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $70.00 from $85.00.
Ameresco (AMRC) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $61.00 from $62.00.
Ameresco (AMRC) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $37.00 from $38.00.
American Axle & Manufacturing (DCH) — Barclays maintains its Equal Weight rating and lowers its price target to $6.00 from $8.00.
American Integrity Insurance Group (AII) — Citizens Jmp maintains its Market Outperform rating and raises its price target to $32.00 from $29.00.
American Public Education (APEI) — Truist Financial maintains its Hold rating and lowers its price target to $41.00 from $55.00.
American Water Works (AWK) — Argus maintains its Buy rating and raises its price target to $165.00 from $155.00.
Apple (AAPL) — China Renaissance upgrades from Hold to Buy with a price target of $425.00.
Archer Aviation (ACHR) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $9.50 from $12.00.
Ardent Health (ARDT) — Mizuho sets a price target of $21.00.
Astronics (ATRO) — TD Cowen maintains its Buy rating and lowers its price target to $80.00 from $90.00.
Atlas Energy Solutions (AESI) — Barclays maintains its Equal Weight rating and lowers its price target to $7.00 from $13.00.
Atlas Energy Solutions (AESI) — Citigroup maintains its Buy rating and lowers its price target to $16.00 from $17.00.
Autolus Therapeutics (AUTL) — HC Wainwright maintains its Buy rating.
Autolus Therapeutics (AUTL) — UBS Group maintains its Buy rating.
Aviat Networks (AVNW) — B. Riley Financial maintains its Buy rating and lowers its price target to $32.00 from $33.00.
Bain Capital Specialty Finance (BCSF) — Noble Financial maintains its Neutral rating.
Bain Capital Specialty Finance (BCSF) — Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $11.00 from $12.00.
Bandwidth (BAND) — Needham & Company LLC maintains its Buy rating.
Bank of America (BAC) — UBS Group maintains its Buy rating with a price target of $62.00.
Bausch Health Cos (BHC) — Barclays maintains its Equal Weight rating and raises its price target to $9.00 from $7.00.
Beachbody (BODI) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $12.00 from $16.00.
Beam Therapeutics (BEAM) — Wedbush maintains its Outperform rating and raises its price target to $33.00 from $30.00.
Belden (BDC) — Jefferies Financial Group initiates coverage with a Hold rating with a price target of $114.00.
Bicara Therapeutics (BCAX) — HC Wainwright maintains its Buy rating and lowers its price target to $36.00 from $42.00.
BILL (BILL) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $64.00 from $60.00.
BILL (BILL) — UBS Group resumes coverage with a Buy rating and raises its price target to $64.00 from $60.00.
Bitdeer Technologies Group (BTDR) — Barclays maintains its Overweight rating and lowers its price target to $14.00 from $17.00.
Bitdeer Technologies Group (BTDR) — HC Wainwright maintains its Buy rating.
Bitdeer Technologies Group (BTDR) — Needham & Company LLC maintains its Buy rating and lowers its price target to $18.00 from $20.00.
BJ’s Wholesale Club (BJ) — Bank of America maintains its Neutral rating.
Black Rock Coffee Bar (BRCB) — DA Davidson maintains its Buy rating and raises its price target to $13.00 from $10.00.
Black Rock Coffee Bar (BRCB) — Robert W. Baird maintains its Neutral rating and raises its price target to $10.00 from $8.00.
Block (XYZ) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $110.00 from $95.00.
Block (XYZ) — Truist Financial maintains its Buy rating and raises its price target to $95.00 from $89.00.
Boeing (BA) — Susquehanna maintains its Positive rating.
BridgeBio Oncology Therapeutics (BBOT) — Wedbush maintains its Outperform rating with a price target of $9.00.
BrightView (BV) — Robert W. Baird maintains its Outperform rating and lowers its price target to $12.00 from $14.00.
Bullish (BLSH) — JPMorgan Chase & Co. maintains its Neutral rating and raises its price target to $28.00 from $25.00.
Camden National (CAC) — Stephens maintains its Equal Weight rating and raises its price target to $59.00 from $58.00.
Camden Property Trust (CPT) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $107.00 from $118.00.
Camping World (CWH) — Truist Financial maintains its Buy rating and lowers its price target to $7.00 from $10.00.
Canaan (CAN) — BTIG Research maintains its Buy rating and lowers its price target to $1.00 from $2.00.
CareDx (CDNA) — Piper Sandler initiates coverage with a Overweight rating with a price target of $100.00.
Carlsmed (CARL) — BTIG Research maintains its Buy rating and raises its price target to $26.00 from $24.00.
Carlsmed (CARL) — Needham & Company LLC maintains its Buy rating and raises its price target to $22.00 from $17.00.
Carlsmed (CARL) — Truist Financial maintains its Buy rating and raises its price target to $23.00 from $20.00.
Casella Waste Systems (CWST) — Barclays maintains its Overweight rating and raises its price target to $109.00 from $104.00.
Centrus Energy (LEU) — Jefferies Financial Group maintains its Hold rating.
Cigna Group (CI) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $390.00 from $387.00.
Cigna Group (CI) — Wells Fargo & Company sets a price target of $390.00.
Citizens (CIZN) — Jefferies Financial Group sets a price target of $32.00.
Citizens (CIZN) — UBS Group maintains its Market Outperform rating.
Cognex (CGNX) — Jefferies Financial Group initiates coverage with a Buy rating with a price target of $64.00.
CommVault Systems (CVLT) — Mizuho sets a price target of $200.00.
CommVault Systems (CVLT) — UBS Group maintains its Outperform rating.
Concentra Group Holdings Parent (CON) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $49.00 from $42.00.
ConocoPhillips (COP) — Freedom Broker downgrades from Buy to Hold and raises its price target to $138.00 from $122.00.
ConocoPhillips (COP) — The Goldman Sachs Group maintains its Buy rating.
Corbus Pharmaceuticals (CRBP) — Oppenheimer maintains its Outperform rating.
Core & Main (CNM) — Barclays maintains its Overweight rating and lowers its price target to $60.00 from $61.00.
Core & Main (CNM) — Robert W. Baird maintains its Outperform rating and lowers its price target to $54.00 from $57.00.
CoreWeave (CRWV) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $100.00 from $176.00.
CoreWeave (CRWV) — Citigroup maintains its Buy rating and raises its price target to $149.00 from $128.00.
CoreWeave (CRWV) — DA Davidson maintains its Neutral rating and lowers its price target to $45.00 from $100.00.
CoreWeave (CRWV) — Mizuho sets a price target of $68.00.
CoreWeave (CRWV) — Needham & Company LLC maintains its Hold rating.
CoreWeave (CRWV) — Stifel Nicolaus maintains its Hold rating and lowers its price target to $60.00 from $120.00.
CoreWeave (CRWV) — Truist Financial maintains its Buy rating and lowers its price target to $115.00 from $165.00.
Corning (GLW) — Jefferies Financial Group initiates coverage with a Buy rating with a price target of $134.00.
Costco Wholesale (COST) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $1,155.00 from $1,143.00.
Crescent Capital BDC (CCAP) — LADENBURG THALM/SH SH downgrades from Buy to Neutral with a price target of $10.00.
Crescent Capital BDC (CCAP) — Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $10.00 from $11.00.
Cullinan Therapeutics (CGEM) — Wedbush maintains its Outperform rating and raises its price target to $44.00 from $42.00.
D-Wave Quantum (QBTS) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $31.00 from $35.00.
D-Wave Quantum (QBTS) — Needham & Company LLC maintains its Buy rating and lowers its price target to $20.00 from $40.00.
D-Wave Quantum (QBTS) — Rosenblatt Securities maintains its Buy rating and lowers its price target to $30.00 from $43.00.
D-Wave Quantum (QBTS) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $23.00 from $35.00.
Delek US (DK) — Freedom Broker upgrades from Hold to Buy and raises its price target to $88.00 from $86.00.
Doximity (DOCS) — Barclays maintains its Equal Weight rating and raises its price target to $30.00 from $27.00.
Draganfly (DPRO) — Needham & Company LLC maintains its Buy rating and lowers its price target to $6.00 from $8.00.
Eaton (ETN) — Jefferies Financial Group initiates coverage with a Neutral rating with a price target of $395.00.
Eaton (ETN) — JPMorgan Chase & Co. changes its rating from Overweight to Neutral with a price target of $395.00.
Ecovyst (ECVT) — Citigroup maintains its Neutral rating and lowers its price target to $12.00 from $13.00.
Edwards Lifesciences (EW) — TD Cowen maintains its Buy rating and raises its price target to $121.00 from $117.00.
Elmet Group (ELMT) — Canaccord Genuity Group maintains its Buy rating and raises its price target to $28.00 from $26.00.
Energizer (ENR) — UBS Group maintains its Neutral rating.
Energy Vault (NRGV) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $12.00 from $7.00.
Energy Vault (NRGV) — Citigroup maintains its Buy rating and raises its price target to $5.00 from $4.75.
EPAM Systems (EPAM) — Citigroup maintains its Neutral rating and raises its price target to $172.00 from $140.00.
EquipmentShare.com (EQPT) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $17.00 from $19.00.
Ermenegildo Zegna (ZGN) — TD Cowen maintains its Buy rating and raises its price target to $17.00 from $16.00.
Essential Utilities (WTRG) — Argus maintains its Buy rating and raises its price target to $50.00 from $45.00.
Essex Property Trust (ESS) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $285.00 from $302.00.
eToro Group (ETOR) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $40.00 from $47.00.
eToro Group (ETOR) — Mizuho sets a price target of $33.00.
eToro Group (ETOR) — Needham & Company LLC maintains its Buy rating and lowers its price target to $45.00 from $54.00.
eToro Group (ETOR) — TD Cowen maintains its Buy rating and lowers its price target to $26.00 from $33.00.
Eupraxia Pharmaceuticals (EPRX) — HC Wainwright maintains its Buy rating and raises its price target to $16.00 from $11.00.
Exagen (XGN) — BTIG Research maintains its Buy rating with a price target of $9.00.
Exagen (XGN) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $9.00 from $11.00.
Expedia Group (EXPE) — Argus maintains its Buy rating and lowers its price target to $300.00 from $360.00.
FactSet Research Systems (FDS) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $321.00 from $300.00.
FactSet Research Systems (FDS) — Stifel Nicolaus maintains its Hold rating and raises its price target to $325.00 from $292.00.
Fidelity National Information Services (FIS) — Sanford C. Bernstein maintains its Market Perform rating and lowers its price target to $31.00 from $48.00.
Firefly Aerospace (FLY) — B. Riley Financial maintains its Buy rating and raises its price target to $54.00 from $40.00.
Firefly Aerospace (FLY) — Barclays maintains its Equal Weight rating and raises its price target to $35.00 from $34.00.
Fiserv (FISV) — Citigroup maintains its Neutral rating and raises its price target to $67.00 from $62.00.
Fiserv (FISV) — Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $70.00 from $60.00.
Five Below (FIVE) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $279.00 from $272.00.
Flywire (FLYW) — Truist Financial maintains its Hold rating and raises its price target to $23.00 from $19.00.
Forgent Power Solutions (FPS) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $35.00 from $49.00.
FormFactor (FORM) — Jefferies Financial Group changes its rating from Hold to Buy with a price target of $102.00.
Fortrea (FTRE) — Mizuho downgrades from Neutral to Underperform and raises its price target to $19.00 from $16.00.
Freenome (FRNM) — BTIG Research maintains its Buy rating.
FS KKR Capital (FSK) — B. Riley Financial maintains its Neutral rating and raises its price target to $12.00 from $11.00.
GE HealthCare Technologies (GEHC) — Argus maintains its Buy rating and raises its price target to $110.00 from $85.00.
GE Vernova (GEV) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $1,000.00 from $1,035.00.
Gen Digital (GEN) — Argus maintains its Buy rating and raises its price target to $35.00 from $32.00.
Gevo (GEVO) — HC Wainwright maintains its Buy rating.
GFL Environmental (GFL) — JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $40.00 from $42.00.
Gilat Satellite Networks (GILT) — Needham & Company LLC maintains its Buy rating and lowers its price target to $11.00 from $20.00.
Gladstone Investment (GAIN) — LADENBURG THALM/SH SH upgrades from Neutral to Buy with a price target of $17.00.
Global Medical REIT (XRN) — Citizens Jmp maintains its Market Outperform rating and lowers its price target to $35.00 from $42.00.
Global Payments (GPN) — Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $100.00 from $86.00.
Globant (GLOB) — Guggenheim downgrades from Buy to Neutral.
GMR Solutions (GMRS) — Citigroup maintains its Buy rating and lowers its price target to $15.00 from $17.00.
Gossamer Bio (GOSS) — Wedbush maintains its Neutral rating with a price target of $32.00.
Grocery Outlet (GO) — Guggenheim maintains its Neutral rating.
Grocery Outlet (GO) — TD Cowen maintains its Hold rating and raises its price target to $14.00 from $12.00.
Grocery Outlet (GO) — Telsey Advisory Group sets a price target of $14.00.
Grocery Outlet (GO) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $13.00 from $11.00.
Guidewire Software (GWRE) — Jefferies Financial Group initiates coverage with a Hold rating with a price target of $175.00.
Halozyme Therapeutics (HALO) — Morgan Stanley downgrades from Overweight to Equal Weight and raises its price target to $109.00 from $105.00.
Harrow (HROW) — BTIG Research maintains its Buy rating with a price target of $63.00.
Herbalife (HLF) — Argus maintains its Buy rating and raises its price target to $20.00 from $15.00.
Hilltop (HTH) — Piper Sandler maintains its Neutral rating and lowers its price target to $36.00 from $42.00.
HIVE Digital Technologies (HIVE) — B. Riley Financial maintains its Buy rating and lowers its price target to $5.00 from $8.00.
HIVE Digital Technologies (HIVE) — HC Wainwright maintains its Buy rating and lowers its price target to $5.00 from $6.00.
Horizon Quantum Computing Pte. (HQ) — Needham & Company LLC maintains its Buy rating and lowers its price target to $19.00 from $20.00.
Hubbell (HUBB) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $470.00 from $486.00.
Humacyte (HUMA) — Barclays maintains its Equal Weight rating and raises its price target to $0.60 from $0.50.
Humana (HUM) — TD Cowen maintains its Hold rating and raises its price target to $430.00 from $370.00.
IMAX (IMAX) — BTIG Research maintains its Neutral rating.
Inovio Pharmaceuticals (INO) — Piper Sandler maintains its Overweight rating and lowers its price target to $6.00 from $8.00.
iRhythm Technologies (IRTC) — Stephens maintains its Overweight rating and lowers its price target to $120.00 from $160.00.
Janus International Group (JBI) — KeyCorp maintains its Overweight rating and lowers its price target to $7.00 from $9.00.
JBT Marel (JBTM) — Jefferies Financial Group initiates coverage with a Hold rating with a price target of $142.00.
Jerash Holdings (US) (JRSH) — DA Davidson maintains its Buy rating and raises its price target to $10.00 from $6.00.
Johnson Controls International (JCI) — JPMorgan Chase & Co. resumes coverage with a Neutral rating with a price target of $160.00.
KKR & Co. Inc. (KKR) — Piper Sandler maintains its Overweight rating and raises its price target to $125.00 from $121.00.
Kopin (KOPN) — Oppenheimer maintains its Outperform rating.
KORU Medical Systems (KRMD) — Piper Sandler maintains its Neutral rating and lowers its price target to $4.50 from $5.00.
Landstar System (LSTR) — Morgan Stanley maintains its Underweight rating and lowers its price target to $130.00 from $145.00.
Lantronix (LTRX) — Canaccord Genuity Group maintains its Buy rating and lowers its price target to $10.50 from $11.00.
Legacy Housing (LEGH) — B. Riley Financial maintains its Neutral rating and raises its price target to $27.00 from $24.00.
Legend Biotech (LEGN) — Barclays maintains its Overweight rating and lowers its price target to $61.00 from $68.00.
Legend Biotech (LEGN) — Morgan Stanley maintains its Overweight rating and lowers its price target to $43.00 from $49.00.
Legend Biotech (LEGN) — Oppenheimer maintains its Market Perform rating and lowers its price target to $25.00 from $40.00.
Legend Biotech (LEGN) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $50.00 from $56.00.
Leonardo DRS (DRS) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $48.00 from $53.00.
Life360 (LIF) — Bank of America downgrades from Buy to Neutral and lowers its price target to $45.00 from $60.00.
Life360 (LIF) — Citigroup maintains its Buy rating and lowers its price target to $56.60 from $60.00.
Life360 (LIF) — UBS Group sets a price target of $45.00.
Lifeway Foods (LWAY) — BTIG Research maintains its Buy rating with a price target of $30.00.
Ligand Pharmaceuticals (LGND) — Barclays maintains its Overweight rating and raises its price target to $350.00 from $345.00.
Lineage (LINE) — Robert W. Baird maintains its Neutral rating and lowers its price target to $40.00 from $43.00.
Liquidia (LQDA) — Bank of America maintains its Neutral rating with a price target of $54.00.
Liquidia (LQDA) — Needham & Company LLC maintains its Buy rating and raises its price target to $66.00 from $58.00.
Liquidia (LQDA) — Raymond James Financial upgrades from Outperform to Strong-Buy and raises its price target to $77.00 from $53.00.
Liquidia (LQDA) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $40.00 from $33.00.
Littelfuse (LFUS) — Jefferies Financial Group changes its rating from Hold to Buy with a price target of $471.00.
Lucid Group (LCID) — Citigroup maintains its Buy rating and lowers its price target to $9.00 from $11.00.
Lumexa Imaging (LMRI) — Raymond James Financial maintains its Strong-Buy rating with a price target of $19.00.
Lumexa Imaging (LMRI) — UBS Group maintains its Strong-Buy rating.
LuxExperience B.V. (LUXE) — TD Cowen maintains its Buy rating and raises its price target to $12.00 from $11.00.
MARA (MARA) — JPMorgan Chase & Co. maintains its Underweight rating and lowers its price target to $9.00 from $11.00.
Martin Marietta Materials (MLM) — Stifel Nicolaus maintains its Buy rating and raises its price target to $653.00 from $629.00.
Mastercard (MA) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $764.00 from $730.00.
Maze Therapeutics (MAZE) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $51.00 from $53.00.
Medallion Financial (MFIN) — Piper Sandler maintains its Neutral rating and lowers its price target to $10.00 from $12.00.
Mercury Systems (MRCY) — JPMorgan Chase & Co. upgrades from Neutral to Overweight and lowers its price target to $102.00 from $110.00.
Mercury Systems (MRCY) — Piper Sandler maintains its Overweight rating with a price target of $107.00.
Mid-America Apartment Communities (MAA) — Morgan Stanley downgrades from Overweight to Equal Weight and lowers its price target to $134.00 from $147.00.
Mirum Pharmaceuticals (MIRM) — Citigroup maintains its Buy rating and raises its price target to $194.00 from $184.00.
Morgan Stanley Direct Lending Fund (MSDL) — Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $14.00 from $16.00.
Mosaic (MOS) — Freedom Broker downgrades from Hold to Sell and raises its price target to $18.00 from $17.00.
Mplx (MPLX) — Barclays maintains its Overweight rating and lowers its price target to $61.00 from $63.00.
MSC Income Fund (MSIF) — B. Riley Financial maintains its Buy rating and raises its price target to $14.00 from $13.00.
National Fuel Gas (NFG) — KeyCorp maintains its Overweight rating and lowers its price target to $91.00 from $95.00.
NewAmsterdam Pharma (NAMS) — Cantor Fitzgerald maintains its Overweight rating and raises its price target to $61.00 from $52.00.
NexGen Energy (NXE) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $12.00 from $14.00.
NIKE (NKE) — KeyCorp maintains its Sector Weight rating.
Northern Oil and Gas (NOG) — Citigroup maintains its Buy rating and lowers its price target to $30.00 from $32.00.
nVent Electric (NVT) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $155.00 from $167.00.
NVIDIA (NVDA) — Evercore downgrades from Outperform to Positive.
NVIDIA (NVDA) — Jefferies Financial Group changes its rating from Buy to Hold.
NVIDIA (NVDA) — Morgan Stanley maintains its Overweight rating with a price target of $300.00.
NVIDIA (NVDA) — Raymond James Financial upgrades from Outperform to Strong-Buy.
NVIDIA (NVDA) — Robert W. Baird downgrades from Outperform to Neutral and lowers its price target to $200.00 from $500.00.
Occidental Petroleum (OXY) — Wells Fargo & Company maintains its Overweight rating and lowers its price target to $76.00 from $82.00.
OceanFirst Financial (OCFC) — Piper Sandler maintains its Neutral rating and raises its price target to $19.50 from $18.00.
ODDITY Tech (ODD) — The Goldman Sachs Group maintains its Sell rating.
Omega Healthcare Investors (OHI) — Citigroup maintains its Market Outperform rating.
ON (ONON) — Barclays maintains its Overweight rating and lowers its price target to $42.00 from $44.00.
ON (ONON) — HC Wainwright sets a price target of $43.00.
ON (ONON) — JPMorgan Chase & Co. maintains its Overweight rating and raises its price target to $46.00 from $44.00.
ON (ONON) — KeyCorp maintains its Overweight rating and raises its price target to $42.00 from $37.00.
ON (ONON) — Morgan Stanley maintains its Overweight rating and raises its price target to $43.00 from $39.00.
Opus Genetics (IRD) — HC Wainwright maintains its Buy rating and raises its price target to $14.00 from $8.00.
Opus Genetics (IRD) — Royal Bank Of Canada maintains its Outperform rating and raises its price target to $11.00 from $9.00.
P3 Health Partners (PIII) — TD Cowen maintains its Hold rating and lowers its price target to $4.00 from $13.00.
Palisade Bio (PALI) — HC Wainwright maintains its Buy rating with a price target of $5.00.
Palladyne AI (PDYN) — Jefferies Financial Group maintains its Hold rating with a price target of $5.50.
Palo Alto Networks (PANW) — Evercore maintains its Outperform rating.
PayPal (PYPL) — Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $60.00 from $55.00.
Paysign (PAYS) — DA Davidson maintains its Buy rating and lowers its price target to $14.00 from $15.00.
Paysign (PAYS) — Maxim Group downgrades from Buy to Hold.
Pediatrix Medical Group (MD) — Mizuho downgrades from Neutral to Underperform with a price target of $28.00.
PepGen (PEPG) — Wedbush maintains its Outperform rating and raises its price target to $10.00 from $4.00.
Phreesia (PHR) — JPMorgan Chase & Co. downgrades from Neutral to Underweight with a price target of $13.00.
Plains All American Pipeline (PAA) — Barclays maintains its Underweight rating and raises its price target to $25.00 from $24.00.
Plains All American Pipeline (PAA) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $25.00 from $23.00.
Plains GP (PAGP) — Barclays maintains its Underweight rating and raises its price target to $25.00 from $24.00.
Plains GP (PAGP) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $25.00 from $23.00.
Plug Power (PLUG) — Susquehanna maintains its Neutral rating and lowers its price target to $1.50 from $1.75.
Praxis Precision Medicines (PRAX) — HC Wainwright maintains its Buy rating.
QuickLogic (QUIK) — Needham & Company LLC maintains its Buy rating and lowers its price target to $12.00 from $20.00.
QumulusAI (QMLS) — B. Riley Financial maintains its Buy rating and lowers its price target to $9.00 from $11.00.
QumulusAI (QMLS) — Chardan Capital maintains its Buy rating with a price target of $13.00.
RB Global (RBA) — Barclays maintains its Overweight rating and raises its price target to $112.00 from $110.00.
Regal Rexnord (RRX) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $195.00 from $196.00.
Republic Services (RSG) — JPMorgan Chase & Co. upgrades from Neutral to Overweight and raises its price target to $295.00 from $265.00.
Resideo Technologies (REZI) — Oppenheimer maintains its Outperform rating and lowers its price target to $25.00 from $27.00.
RideNow Group (RDNW) — Robert W. Baird maintains its Neutral rating and lowers its price target to $5.50 from $9.00.
Rigetti Computing (RGTI) — Jefferies Financial Group maintains its Hold rating with a price target of $12.00.
Rigetti Computing (RGTI) — Mizuho sets a price target of $17.00.
Rigetti Computing (RGTI) — Needham & Company LLC maintains its Buy rating and lowers its price target to $15.00 from $31.00.
Riot Platforms (RIOT) — Keefe Bruyette downgrades from Outperform to Market Perform with a price target of $23.
Rocket Lab (RKLB) — Morgan Stanley maintains its Overweight rating and lowers its price target to $103.00 from $105.00.
Rocket Lab (RKLB) — Needham & Company LLC maintains its Buy rating and lowers its price target to $100.00 from $120.00.
Sally Beauty (SBH) — Canaccord Genuity Group maintains its Buy rating and raises its price target to $25.00 from $20.00.
Sally Beauty (SBH) — Jefferies Financial Group maintains its Hold rating with a price target of $21.00.
Sally Beauty (SBH) — Morgan Stanley maintains its Underweight rating and raises its price target to $19.00 from $13.00.
Satellogic (SATL) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $7.00 from $9.00.
Savers Value Village (SVV) — BTIG Research maintains its Buy rating with a price target of $15.00.
SEA (SE) — Bank of America maintains its Buy rating with a price target of $110.00.
SEA (SE) — TD Cowen maintains its Hold rating and lowers its price target to $90.00 from $100.00.
Select Water Solutions (WTTR) — Citigroup maintains its Buy rating and lowers its price target to $23.00 from $24.00.
Sensata Technologies (ST) — Jefferies Financial Group initiates coverage with a Hold rating with a price target of $40.00.
ServiceTitan (TTAN) — Jefferies Financial Group initiates coverage with a Hold rating with a price target of $86.00.
Solaris Energy Infrastructure (SEI) — Needham & Company LLC maintains its Buy rating and raises its price target to $126.00 from $104.00.
Sonida Senior Living (SNDA) — Royal Bank Of Canada maintains its Outperform rating and lowers its price target to $43.00 from $48.00.
Spire Global (SPIR) — Stifel Nicolaus maintains its Buy rating and lowers its price target to $20.00 from $24.00.
SPX Technologies (SPXC) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $190.00 from $225.00.
Starwood Property Trust (STWD) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $15.50 from $16.00.
Stellus Capital Investment (SCM) — Loop Capital maintains its Neutral rating.
Stellus Capital Investment (SCM) — Noble Financial maintains its Neutral rating.
STUB (STUB) — JPMorgan Chase & Co. maintains its Neutral rating and lowers its price target to $8.00 from $11.00.
Suja Life (SUJA) — Jefferies Financial Group maintains its Buy rating.
Suja Life (SUJA) — The Goldman Sachs Group downgrades from Buy to Neutral with a price target of $12.00.
Surgery Partners (SGRY) — Mizuho downgrades from Outperform to Neutral and raises its price target to $25.00 from $19.00.
Surgery Partners (SGRY) — TD Cowen maintains its Hold rating and raises its price target to $25.00 from $23.50.
Surrozen (SRZN) — Guggenheim maintains its Buy rating with a price target of $80.00.
Symbotic (SYM) — Jefferies Financial Group changes its rating from Buy to Hold with a price target of $35.00.
Teradyne (TER) — Jefferies Financial Group initiates coverage with a Buy rating with a price target of $284.00.
Terrestrial Energy (IMSR) — Northland Securities downgrades from Outperform to Market Perform with a price target of $3.25.
The Hartford Insurance Group (HIG) — Wells Fargo & Company downgrades from Overweight to Equal Weight and lowers its price target to $139.00 from $158.00.
Thryv (THRY) — Needham & Company LLC maintains its Buy rating.
TIM (TIMB) — Barclays maintains its Equal Weight rating and lowers its price target to $20.00 from $22.00.
Toast (TOST) — Sanford C. Bernstein downgrades from Outperform to Market Perform and lowers its price target to $38.00 from $45.00.
Trade Desk (TTD) — Cantor Fitzgerald maintains its Neutral rating and raises its price target to $15.00 from $14.00.
Trade Desk (TTD) — Piper Sandler maintains its Neutral rating and raises its price target to $16.00 from $14.00.
Trade Desk (TTD) — Wells Fargo & Company maintains its Equal Weight rating and raises its price target to $15.00 from $12.00.
Trane Technologies (TT) — JPMorgan Chase & Co. maintains its Overweight rating and lowers its price target to $480.00 from $550.00.
Transdigm Group (TDG) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $1,405.00 from $1,300.00.
Transdigm Group (TDG) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $1,300.00 from $1,200.00.
Transdigm Group (TDG) — TD Cowen maintains its Buy rating and raises its price target to $1,350.00 from $1,300.00.
TriSalus Life Sciences (TLSI) — HC Wainwright maintains its Buy rating and lowers its price target to $10.00 from $12.00.
Tyra Biosciences (TYRA) — HC Wainwright maintains its Buy rating and lowers its price target to $27.00 from $29.00.
Tyra Biosciences (TYRA) — Wedbush maintains its Outperform rating and raises its price target to $57.00 from $53.00.
Unilever (UL) — Deutsche Bank upgrades from Hold to Buy.
Unilever (UL) — Deutsche Bank Aktiengesellschaft upgrades from Hold to Buy.
United Dominion Realty Trust (UDR) — Morgan Stanley maintains its Equal Weight rating and lowers its price target to $41.00 from $42.00.
Universal Health Services (UHS) — Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $207.00 from $183.00.
Upstream Bio (UPB) — HC Wainwright maintains its Buy rating with a price target of $18.00.
USA Rare Earth (USAR) — Jefferies Financial Group maintains its Buy rating.
Veeva Systems (VEEV) — Wells Fargo & Company maintains its Overweight rating and raises its price target to $400.00 from $330.00.
Veracyte (VCYT) — Stephens maintains its Overweight rating and lowers its price target to $40.00 from $55.00.
Vertiv (VRT) — JPMorgan Chase & Co. resumes coverage with a Neutral rating with a price target of $240.00.
Visa (V) — Sanford C. Bernstein maintains its Outperform rating and raises its price target to $486.00 from $475.00.
Walmart (WMT) — Bank of America maintains its Buy rating.
WESCO International (WCC) — Barclays maintains its Overweight rating and raises its price target to $450.00 from $437.00.
WhiteFiber (WYFI) — BTIG Research maintains its Buy rating and lowers its price target to $30.00 from $50.00.
WhiteFiber (WYFI) — HC Wainwright maintains its Buy rating and raises its price target to $36.00 from $34.00.
WhiteFiber (WYFI) — Needham & Company LLC maintains its Buy rating and lowers its price target to $37.00 from $41.00.
Winnebago Industries (WGO) — Truist Financial maintains its Buy rating and raises its price target to $39.00 from $35.00.
Wix.com (WIX) — Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $80.00 from $90.00.
Wix.com (WIX) — Citigroup maintains its Neutral rating and lowers its price target to $71.00 from $72.00.
Wix.com (WIX) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $73.00 from $65.00.
Wix.com (WIX) — Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $58.00 from $60.00.
Wix.com (WIX) — Wells Fargo & Company maintains its Equal Weight rating and lowers its price target to $63.00 from $64.00.
Xeris Biopharma (XERS) — Barclays maintains its Overweight rating and raises its price target to $18.00 from $14.00.
Zebra Technologies (ZBRA) — Jefferies Financial Group initiates coverage with a Buy rating with a price target of $382.00.
Zeta Global (ZETA) — Morgan Stanley maintains its Equal Weight rating and raises its price target to $33.00 from $25.00.
Ziff Davis (ZD) — Citigroup maintains its Neutral rating and lowers its price target to $56.00 from $59.00.
Zymeworks (ZYME) — Citigroup maintains its Buy rating and raises its price target to $44.00 from $39.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business
STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)
Bank of Canada Looks to Pause rates as Recession Looms
American Analyst Updates: Nov 10th, 2026
American Analyst Updates: Nov 9th, 2026
American Analyst Updates: Nov 6th, 2026
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.